胰岛素抵抗性血管障碍分子水平发病机制研究进展

被引:8
作者
苏芳
赵丽
机构
[1] 沈阳市第七人民医院内科
关键词
一氧化氮; 一氧化氮合酶; 内皮,血管;
D O I
暂无
中图分类号
R587 [胰岛疾病];
学科分类号
1002 ; 100201 ;
摘要
本文介绍胰岛素抵抗状态下内皮机能障碍发生机制的最新研究进展。一些研究表明,在胰岛素抵抗状态下,因血管壁肾素—血管紧张素系统机能亢进,导致了血管张力增加,另外,又因血管内皮嘌呤代谢异常,导致了内皮型一氧化氮合成酶(eNOS)脱耦联及功能异常,使经 eNOS 途径生成的 O2- 增多,而 NO 生成减少。此为引起血管内皮机能损害的机制之一。
引用
收藏
页码:206 / 207
页数:2
相关论文
共 6 条
[1]   Diabetes [P]. 
英国专利 :GB201117172D0 ,2011-11-16
[2]  
Molecular mechanisms of impaired endothelial function associated with insulin resistance. Shinozaki K,Kashiwagi A,Masada M,et al. Curr Drug Targets Cardiovasc Hue Matol Disord . 2004
[3]  
Molecular Mechanisms of endothelial dysfunction in the insulin-resistant state the roles of abnormal pteridine metabolism. Shinozaki K,Kashiwagi A,Masada M,et al. Pteridines . 2003
[4]  
Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Shinozaki K,Ayajiki K,Nishio Y.et al. Journal of Hypertension . 2004
[5]  
Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats. Shinozaki,Nishio Y,Okamura T,et al. Circulation Research . 2000
[6]  
Coronary endotbelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress. Shinozaki K,Hirayama A,Nishio Y,et al. Journal of the American College of Cardiology . 2001